U.S. Bancorp Delivers Another Dividend Increase: Assessing the Payout

U.S. Bancorp’s 3.8% dividend hike lifts its annual payout to $2.16 per share, backed by a manageable payout ratio, solid capital position and a long record of steady dividend growth.

U.S. Bancorp (NYSE:USB)’s latest dividend increase adds another step to an already long-running shareholder return program. The bank has raised its quarterly common-stock dividend by 3.8% to $0.54 per share, up from $0.52. At the new rate, shareholders will receive $2.16 per share annually, with the next payment scheduled for October 15, 2026.

Dividend Yield: Around 3.4%

At a recent share price of about $62.84, U.S. Bancorp’s new annualized dividend of $2.16 translates into a forward dividend yield of roughly 3.4%. That puts USB firmly in the income-oriented portion of the large U.S. banking sector. The yield is not exceptionally high for a bank, but it provides a meaningful cash return while still leaving the company room to retain capital for growth and balance-sheet needs. The yield has also moved lower over time as the stock price has risen. For context, the yield was above 4% earlier in 2026 when the shares were trading closer to $50-$55.

Dividend Growth: Steady Rather Than Aggressive

The latest increase continues U.S. Bancorp’s pattern of relatively modest but consistent dividend growth. The bank raised its quarterly payout from $0.49 to $0.50 in 2024, then from $0.50 to $0.52 in 2025, and now to $0.54 in 2026. That means the dividend has increased by about 10% over the past two years, although the pace has been measured rather than aggressive. U.S. Bancorp has also maintained a much longer record behind those recent increases, with 15 consecutive years of dividend increases according to current dividend data.

This is important for income investors because the appeal of USB is not simply its current yield. The company has demonstrated a willingness to gradually increase the payout as its earnings and capital position allow.

Dividend Payout Looks Manageable

U.S. Bancorp’s dividend does not appear to be consuming an excessive portion of its earnings. The company reported 2025 diluted EPS of $4.62, while dividends declared per common share totaled $2.04 for the year. That works out to a payout of roughly 44% of earnings.

Current forward-looking dividend data puts the payout ratio in a similar range, at roughly 37%-43% depending on the earnings measure used. That leaves a reasonable portion of profits inside the business. For a bank, this matters because retained earnings help strengthen capital and support future lending, acquisitions, buybacks, and dividend increases.

Cash Flow: The Dividend Is Supported by the Bank’s Capital Generation

Cash flow needs to be viewed somewhat differently for a bank than for an industrial company. Traditional free cash flow is less useful because deposits, loans, and securities can cause large swings in operating and investing cash flows. More relevant is whether the bank generates enough earnings and capital to support shareholder distributions. U.S. Bancorp paid $3.17 billion in common dividends during 2025, compared with $3.09 billion in 2024 and $2.97 billion in 2023. At the same time, the company generated $7.97 billion of operating cash flow in 2025 at the consolidated level.

The bank’s parent company also received $6.25 billion in dividends from its banking subsidiary in 2025, up from $4.8 billion in 2024. That provides an important source of liquidity for the parent company’s own dividend obligations and other capital-allocation activities.

Capital Position Supports the Dividend

For a bank dividend, capital strength is arguably just as important as earnings. U.S. Bancorp’s latest stress-test-related disclosures showed a 10.8% CET1 ratio as of March 31, 2026, while the applicable minimum requirement, including its stress capital buffer, was 7.1%. That provides a meaningful capital cushion around the common dividend. It also helps explain why U.S. Bancorp was able to proceed with the 3.8% increase while continuing to retain capital and maintain other shareholder-return options.

The bank had also retained $4.1 billion of capacity under its existing $5 billion share-repurchase authorization at the end of the first quarter.

Long-Term Dividend Record

U.S. Bancorp’s dividend history is one of the stronger parts of the income story. The bank has maintained uninterrupted dividend payments for decades, while the recent record shows a gradual progression from $0.48 per quarter in 2023 to $0.49 in 2024, $0.52 in 2025, and now $0.54 in 2026. The growth rate is therefore not spectacular, but it has been relatively dependable. That makes USB more of a steady dividend-growth and income stock than a high-growth dividend story.

Dividend Safety

The current dividend appears reasonably supported by three factors: a payout ratio below 50%, ongoing earnings generation, and a capital position comfortably above regulatory minimums. The latest 3.8% increase is also relatively conservative, suggesting the bank is not stretching its payout to deliver a larger headline increase.

There are still risks. Banking dividends ultimately depend on earnings, credit quality, capital requirements, and regulatory approval. A weaker economic environment or deterioration in the bank’s capital position could limit future increases even if the current dividend remains intact.

Bottom Line

U.S. Bancorp’s latest dividend increase reinforces the company’s profile as a steady income and dividend-growth bank. The new $0.54 quarterly payout, or $2.16 annually, produces a yield of roughly 3.4%, while the payout ratio remains at a manageable level.

The bigger attraction is the combination of current income, a 15-year streak of dividend increases, moderate payout requirements, and a solid capital cushion. The trade-off is that dividend growth has been fairly restrained. In other words, USB’s dividend case is less about rapid payout expansion and more about collecting a respectable yield while benefiting from a bank that has historically increased its distribution at a measured pace.

READ NEXT: Lilly’s Foundayo Quickly Gains Ground in the Oral Weight-Loss Market and Abbott Faces $384 Million Cost as Infant Formula Legal Risks Persist 

This article is originally published at Insider Monkey.